Fibroblast Biology. Effector Signals Released by the Synovial Fibroblast in Arthritis

Overview

Journal Arthritis Res

Specialty Rheumatology

Date 2000 Nov 30

PMID 11094448

Citations 57

Authors

C Ritchlin

Affiliations

Soon will be listed here.

Abstract

There is mounting evidence indicating that the synovial fibroblast is a direct effector of tissue injury and matrix remodeling in inflammatory synovitis. Through the elaboration of effector signals including cytokines and chemokines, mesenchymal cells stimulate or suppress inflammation via autocrine and paracrine mechanisms. Synovial fibroblasts are the principal cells mediating joint destruction through secretion of metalloproteinases, and recent evidence suggests that they may also promote bone resorption by stimulating osteoclastogenesis. Moreover, they may play an integral role in the initial phases of synovitis by releasing chemokines that recruit leukocytes to the joint, and cytokines that trigger angiogenesis. Studies focusing on synoviocyte-leukocyte interactions mediated via the cytokine network and the role of cell-cell contact in driving synoviocyte activation will help define the complex interplay that leads to the initiation and perpetuation of synovial inflammation.

Citing Articles

Transient receptor potential vanilloid 1: A potential therapeutic target for the treatment of osteoarthritis and rheumatoid arthritis.

Liao Z, Umar M, Huang X, Qin L, Xiao G, Chen Y Cell Prolif. 2023; 57(3):e13569.

PMID: 37994506 PMC: 10905355. DOI: 10.1111/cpr.13569.

NIH/3T3 Fibroblasts Selectively Activate T Cells Specific for Posttranslationally Modified Collagen Type II.

Dzhambazov B, Batsalova T, Merky P, Lange F, Holmdahl R Int J Mol Sci. 2023; 24(13).

PMID: 37445989 PMC: 10341784. DOI: 10.3390/ijms241310811.

Association between SYVN1 and SEL1 genetic polymorphisms and remission in rheumatoid arthritis patients treated with TNF-α inhibitors: a machine learning approach.

Kim W, Yeon H, Kim J, Kim J, Kim J, Kim H Immunol Res. 2023; 71(5):709-716.

PMID: 37119459 DOI: 10.1007/s12026-023-09382-4.

Fibronectin-1 is a dominant mechanism for rheumatoid arthritis via the mediation of synovial fibroblasts activity.

Yang J, Zhang Y, Liang J, Yang X, Liu L, Zhao H Front Cell Dev Biol. 2022; 10:1010114.

PMID: 36225320 PMC: 9548557. DOI: 10.3389/fcell.2022.1010114.

Hyaluronic acid-green tea catechin conjugates as a potential therapeutic agent for rheumatoid arthritis.

Lee F, Bae K, Ng S, Yamashita A, Kurisawa M RSC Adv. 2022; 11(24):14285-14294.

PMID: 35423998 PMC: 8697692. DOI: 10.1039/d1ra01491a.

References

Maurice M, Nakamura H, Gringhuis S, Okamoto T, Yoshida S, Kullmann F . Expression of the thioredoxin-thioredoxin reductase system in the inflamed joints of patients with rheumatoid arthritis. Arthritis Rheum. 1999; 42(11):2430-9. DOI: 10.1002/1529-0131(199911)42:11<2430::AID-ANR22>3.0.CO;2-6. View

Leech M, Metz C, Hall P, Hutchinson P, Gianis K, Smith M . Macrophage migration inhibitory factor in rheumatoid arthritis: evidence of proinflammatory function and regulation by glucocorticoids. Arthritis Rheum. 1999; 42(8):1601-8. DOI: 10.1002/1529-0131(199908)42:8<1601::AID-ANR6>3.0.CO;2-B. View

Fibbe W, Van Damme J, Billiau A, Duinkerken N, Lurvink E, Ralph P . Human fibroblasts produce granulocyte-CSF, macrophage-CSF, and granulocyte-macrophage-CSF following stimulation by interleukin-1 and poly(rI).poly(rC). Blood. 1988; 72(3):860-6. View

Lafyatis R, Remmers E, Roberts A, Yocum D, Sporn M, Wilder R . Anchorage-independent growth of synoviocytes from arthritic and normal joints. Stimulation by exogenous platelet-derived growth factor and inhibition by transforming growth factor-beta and retinoids. J Clin Invest. 1989; 83(4):1267-76. PMC: 303817. DOI: 10.1172/JCI114011. View

Bucala R, Ritchlin C, Winchester R, Cerami A . Constitutive production of inflammatory and mitogenic cytokines by rheumatoid synovial fibroblasts. J Exp Med. 1991; 173(3):569-74. PMC: 2118837. DOI: 10.1084/jem.173.3.569. View

Qu Z, Garcia C, ORourke L, Planck S, Kohli M, Rosenbaum J . Local proliferation of fibroblast-like synoviocytes contributes to synovial hyperplasia. Results of proliferating cell nuclear antigen/cyclin, c-myc, and nucleolar organizer region staining. Arthritis Rheum. 1994; 37(2):212-20. DOI: 10.1002/art.1780370210. View

Katsikis P, Chu C, Brennan F, Maini R, Feldmann M . Immunoregulatory role of interleukin 10 in rheumatoid arthritis. J Exp Med. 1994; 179(5):1517-27. PMC: 2191503. DOI: 10.1084/jem.179.5.1517. View

Ritchlin C, Dwyer E, Bucala R, Winchester R . Sustained and distinctive patterns of gene activation in synovial fibroblasts and whole synovial tissue obtained from inflammatory synovitis. Scand J Immunol. 1994; 40(3):292-8. DOI: 10.1111/j.1365-3083.1994.tb03465.x. View

Koch A, Kunkel S, Strieter R . Cytokines in rheumatoid arthritis. J Investig Med. 1995; 43(1):28-38. View

10.

Kunkel S, Lukacs N, Kasama T, Strieter R . The role of chemokines in inflammatory joint disease. J Leukoc Biol. 1996; 59(1):6-12. DOI: 10.1002/jlb.59.1.6. View

11.

Muller-Ladner U, Kriegsmann J, Franklin B, Matsumoto S, Geiler T, Gay R . Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice. Am J Pathol. 1996; 149(5):1607-15. PMC: 1865262. View

12.

Firestein G . Invasive fibroblast-like synoviocytes in rheumatoid arthritis. Passive responders or transformed aggressors?. Arthritis Rheum. 1996; 39(11):1781-90. DOI: 10.1002/art.1780391103. View

13.

Burmester G, Stuhlmuller B, Keyszer G, Kinne R . Mononuclear phagocytes and rheumatoid synovitis. Mastermind or workhorse in arthritis?. Arthritis Rheum. 1997; 40(1):5-18. DOI: 10.1002/art.1780400104. View

14.

Scott B, Weisbrot L, Greenwood J, Bogoch E, Paige C, Keystone E . Rheumatoid arthritis synovial fibroblast and U937 macrophage/monocyte cell line interaction in cartilage degradation. Arthritis Rheum. 1997; 40(3):490-8. DOI: 10.1002/art.1780400315. View

15.

Fox D . The role of T cells in the immunopathogenesis of rheumatoid arthritis: new perspectives. Arthritis Rheum. 1997; 40(4):598-609. DOI: 10.1002/art.1780400403. View

16.

Okamoto H, Yamamura M, Morita Y, Harada S, Makino H, Ota Z . The synovial expression and serum levels of interleukin-6, interleukin-11, leukemia inhibitory factor, and oncostatin M in rheumatoid arthritis. Arthritis Rheum. 1997; 40(6):1096-105. DOI: 10.1002/art.1780400614. View

17.

Wang A, Wang J, Fisher G, Diamond H . Interleukin-1beta-stimulated invasion of articular cartilage by rheumatoid synovial fibroblasts is inhibited by antibodies to specific integrin receptors and by collagenase inhibitors. Arthritis Rheum. 1997; 40(7):1298-307. DOI: 10.1002/1529-0131(199707)40:7<1298::AID-ART15>3.0.CO;2-#. View

18.

Jackson J, Minton J, Ho M, Wei N, Winkler J . Expression of vascular endothelial growth factor in synovial fibroblasts is induced by hypoxia and interleukin 1beta. J Rheumatol. 1997; 24(7):1253-9. View

19.

Smith R, Smith T, Blieden T, Phipps R . Fibroblasts as sentinel cells. Synthesis of chemokines and regulation of inflammation. Am J Pathol. 1997; 151(2):317-22. PMC: 1858004. View

20.

Koopman W, Moreland L . Rheumatoid arthritis: anticytokine therapies on the horizon. Ann Intern Med. 1998; 128(3):231-3. DOI: 10.7326/0003-4819-128-3-199802010-00010. View